News for 'Drugs Administration'

Natco challenges Gilead's patent on Tamiflu

Natco challenges Gilead's patent on Tamiflu

Rediff.com9 Feb 2011

The company has sought the United States Food and Drug Administration (FDA)'s approval to market a generic version of Tamiflu (oseltamivir phosphate), said Gilead Sciences, the US company that owns the Tamiflu patent. Natco officials declined to comment on the development.

Now, Pfizer, Novartis, GSK under USFDA scanner

Now, Pfizer, Novartis, GSK under USFDA scanner

Rediff.com19 Jul 2008

Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also under the scanner of the US drug regulator, for more or less similar violations as Ranbaxy is alleged to have committed.

53 dead in TN hooch tragedy, govt rules out CBI probe

53 dead in TN hooch tragedy, govt rules out CBI probe

Rediff.com22 Jun 2024

About 140 people out of 193 who were admitted to various government medical facilities after they consumed the spurious liquor on Tuesday night were currently stable, Kallakurichi district collector M S Prasanth said.

Issues with USFDA to take long to resolve: Ranbaxy

Issues with USFDA to take long to resolve: Ranbaxy

Rediff.com9 Nov 2009

Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib.

Sun Pharma, Forest settle US suit on Lexapro

Sun Pharma, Forest settle US suit on Lexapro

Rediff.com13 Jul 2009

Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS, over a pending patent infringement dispute over Forest's blockbuster antidepressant, Lexapro.

Lupin's US arm gets USDFA nod for insomnia tablets

Lupin's US arm gets USDFA nod for insomnia tablets

Rediff.com22 Mar 2010

The company has received a tentative approval for the company's abbreviated new drug application for Eszopiclone tablets from the US Food and Drug Administration, Lupin said in a filing to the Bombay Stock Exchange.

Daiichi pursuing legal action on ex-shareholders

Daiichi pursuing legal action on ex-shareholders

Rediff.com23 May 2013

Says former Ranbaxy owners concealed critical information on probe by US agencies.

New test can predict your level of immunity against COVID-19

New test can predict your level of immunity against COVID-19

Rediff.com10 Aug 2022

Easy access to this kind of test could help people determine what kind of precautions they should take against COVID-19 infection, such as getting an additional booster shot, the researchers said.

GlaxoSmithKline sues Dr Reddy's

GlaxoSmithKline sues Dr Reddy's

Rediff.com31 Dec 2003

GlaxoSmithKline has filed a lawsuit in a United States court against Dr Reddy's Laboratories alleging infringement of patent rights of a generic version of 'Imitrex' drug, used for the treatment of migraine.

Ranbaxy gets nod for Fluoxetine

Ranbaxy gets nod for Fluoxetine

Rediff.com15 Dec 2004

United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n

AstraZeneca sues Ranbaxy over Nexium

AstraZeneca sues Ranbaxy over Nexium

Rediff.com23 Nov 2005

AstraZeneca files suit against Ranbaxy

AstraZeneca files suit against Ranbaxy

Rediff.com22 Nov 2005

Global pharma firm AstraZeneca on Tuesday said it had filed a lawsuit in the United States District Court of New Jersey

US launches biggest crackdown on designer drugs

US launches biggest crackdown on designer drugs

Rediff.com27 Jun 2013

The source of the synthetic drugs was Asia, especially India and China.

US regulators recommend pause on J&J vaccine over rare blood clots

US regulators recommend pause on J&J vaccine over rare blood clots

Rediff.com13 Apr 2021

In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count.

Maharashtra caps mask prices, N-95 to cost max Rs 49

Maharashtra caps mask prices, N-95 to cost max Rs 49

Rediff.com21 Oct 2020

The Maharashtra government has capped the prices of N-95, double and triple layer masks for suppliers and private hospitals in the wake of the Covid-19 pandemic, state health minister Rajesh Tope has said.

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

USFDA bans more products from Ranbaxy

USFDA bans more products from Ranbaxy

Rediff.com24 Jan 2014

The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.

Ranbaxy gets Australia nod for antipsychotic drug

Ranbaxy gets Australia nod for antipsychotic drug

Rediff.com25 Mar 2009

Drug major Ranbaxy on Wednesday said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country.

FDA asks stent makers to get DGCI approval

FDA asks stent makers to get DGCI approval

Rediff.com13 Jun 2005

Acting swiftly on the controversy regarding illegal drug-coated stents, the Maharashtra Food and Drug Administration has asked all stent manufacturers and importers to get valid licenses within the next two months from the Drugs Controller General of

Ranbaxy gets USFDA nod for generic Serzone

Ranbaxy gets USFDA nod for generic Serzone

Rediff.com28 Apr 2003

The United States Food and Drugs Administration has granted Ranbaxy Laboratories a tentative approval to market a generic form of Bristol-Myers' anti-depressant Serzone, US FDA's web site said.

Former Ranbaxy promoters fined Rs 2,600 crore

Former Ranbaxy promoters fined Rs 2,600 crore

Rediff.com5 May 2016

The US arm of Ranbaxy pleaded guilty to seven felonies relating to the manufacture and distribution of certain adulterated drugs

Why Ranbaxy's big setback is not yet over

Why Ranbaxy's big setback is not yet over

Rediff.com18 Sep 2013

US drug regulator's fiat on Mohali factory, after strictures on the two other major Indian units, has numerous negative implications.

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.

Cadila gets tentative FDA nod

Cadila gets tentative FDA nod

Rediff.com15 Jun 2006

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

Why Daiichi is taking Malvinder Singh to court

Why Daiichi is taking Malvinder Singh to court

Rediff.com27 Nov 2013

The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.

Cloud over US FDA inspection

Cloud over US FDA inspection

Rediff.com19 Jul 2008

Two US Congress members have expressed doubts over the quality of inspections conducted by the US Food and Drugs Administration (FDA) on Indian drug manufacturing facilities.

Why Wockhardt's Waluj facility is under lens

Why Wockhardt's Waluj facility is under lens

Rediff.com18 Nov 2013

After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.

Taro faces ban on products in US market

Taro faces ban on products in US market

Rediff.com11 Feb 2009

If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US Food and Drug Administration, it may face ban on many of its products in the US market, made from the facility at Ontorio, Canada. If Taro fails to address the issues raised by the US FDA, it may face ban on many of its products.

JB Chem files 1st ANDA, US FDA

JB Chem files 1st ANDA, US FDA

Rediff.com16 Jan 2003

JB Chemicals & Pharmaceuticals Ltd on Thursday announced the filing of its first Abbreviated New Drug Application with the United States Food and Drug Administration.

Ranbaxy gets USFDA approval for carvedilol tablets

Ranbaxy gets USFDA approval for carvedilol tablets

Rediff.com25 Oct 2004

Pharmaceutical giant Ranbaxy on Monday said that it has received tentative approval from the US Food and Drug Administration to manufacture and market carvedilol tablets for treatment of cardiac disorders including hypertension.\n\n\n\n

Lupin pills hit legal wall in United States

Lupin pills hit legal wall in United States

Rediff.com12 Oct 2009

Teva Women's Health filed a suit this week in the US District Court for New Jersey, claiming that Lupin had filed an abbreviated new drug application with the US Food and Drug Administration, which infringes the patents of Seasonale, its oral contraceptive that limits the number of menstrual periods women have in a year.

Now, easy to buy Viagra in China

Now, easy to buy Viagra in China

Rediff.com30 Sep 2004

The popular anti-impotence drug will be available in about 2,000 drugstores in major cities.

Breast milk compound could fight cancer

Breast milk compound could fight cancer

Rediff.com26 Feb 2008

A slight variation of lactoferrin, known as talactoferrin alfa, helps fight lung cancer, according to research by Dr Atul Varadhachary, president and chief operating officer of the Houston-based Agennix.

Meet India's 10 new dollar billionaires

Meet India's 10 new dollar billionaires

Rediff.com22 Jul 2014

The number of dollar billionaires in India has risen to 55 this year from 46 last year.

Dr Reddy's files for generic Allegra in US

Dr Reddy's files for generic Allegra in US

Rediff.com26 Mar 2003

Indian drugmaker Dr Reddy's Laboratories Ltd said on Wednesday it has filed with the US Food and Drug Administration to market a generic version of Aventis Pharmaceuticals' anti-allergy drug Allegra.

USFDA to set up office in India

USFDA to set up office in India

Rediff.com18 Nov 2008

The US Department of Health and Human Services has decided to employ 10 full-time officials in Delhi -- a country director, four drug inspectors, two senior technical experts in medicines, two technical experts in medical devices and one from the food sector. 'The purpose of the appointment is to help develop food and medical product regulations and agencies improve product safety and conduct inspections in a more timely manner,' said Christopher Kelly, press officer, USFDA.